HPV Self-collection for Cervical Cancer Screening Among Survivors of Sexual Trauma: a Qualitative Study

Overview

Journal BMC Womens Health

Publisher Biomed Central

Specialty Gynecology & Obstetrics

Date 2024 Sep 13

PMID 39272185

Authors

Rachel A Madding

Jessica J Currier

Keenan Yanit

Madeline Hedges

Amanda Bruegl

Affiliations

Soon will be listed here.

Abstract

Intimate partner violence affects 20-30% of women in the United States. Disparities in routine cervical cancer surveillance have been demonstrated in certain populations, including victims of intimate partner violence (IPV). This study examined and assessed the acceptability of high-risk HPV (hrHPV) self-collection among individuals who have experienced IPV. We conducted an observational study using qualitative data collection and analysis. We interviewed individuals with a history of IPV and who currently reside in Oregon. This study identified key themes describing knowledge and attitudes towards cervical cancer screening for individuals who have experienced IPV. They include: guideline knowledge, prior office-based cervical cancer screening experience, barriers to cervical cancer screening, at-home hrHPV self-collection experience, and testing confidence. Participants experienced fewer barriers and expressed increased comfort and control with hrHPV self-collection process. Individuals with a history of IPV have lower rates of cervical cancer screening adherence and higher rates of cervical dysplasia and cancer than other populations. The patient-centered approach of hrHPV self-collection for cervical cancer screening can reduce barriers related to the pelvic exam and empower patients to reduce their risks of developing cervical cancer by enabling greater control of the testing process.

References

Guo F, Hirth J, Berenson A . Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient. J Womens Health (Larchmt). 2017; 26(10):1114-1122. PMC: 5651938. DOI: 10.1089/jwh.2017.6424. View

Winer R, Lin J, Anderson M, Tiro J, Green B, Gao H . Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial. JAMA. 2023; 330(20):1971-1981. PMC: 10685881. DOI: 10.1001/jama.2023.21471. View

. Caring for Patients Who Have Experienced Trauma: ACOG Committee Opinion, Number 825. Obstet Gynecol. 2021; 137(4):e94-e99. DOI: 10.1097/AOG.0000000000004326. View

Sharpe P, Brandt H, McCree D . Knowledge and beliefs about abnormal pap test results and HPV among women with high-risk HPV: results from in-depth interviews. Women Health. 2006; 42(2):107-33. DOI: 10.1300/j013v42n02_07. View

Waller J, Bartoszek M, Marlow L, Wardle J . Barriers to cervical cancer screening attendance in England: a population-based survey. J Med Screen. 2010; 16(4):199-204. DOI: 10.1258/jms.2009.009073. View

Des Marais A, Zhao Y, Hobbs M, Sivaraman V, Barclay L, Brewer N . Home Self-Collection by Mail to Test for Human Papillomavirus and Sexually Transmitted Infections. Obstet Gynecol. 2018; 132(6):1412-1420. PMC: 6249061. DOI: 10.1097/AOG.0000000000002964. View

Arbyn M, Smith S, Temin S, Sultana F, Castle P . Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ. 2018; 363:k4823. PMC: 6278587. DOI: 10.1136/bmj.k4823. View

Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

McDowell M, Pardee D, Peitzmeier S, Reisner S, Agenor M, Alizaga N . Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests. LGBT Health. 2017; 4(4):252-259. DOI: 10.1089/lgbt.2016.0187. View

10.

Musa J, Achenbach C, ODwyer L, Evans C, McHugh M, Hou L . Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis. PLoS One. 2017; 12(9):e0183924. PMC: 5584806. DOI: 10.1371/journal.pone.0183924. View

11.

Oscarsson M, Benzein E, Wijma B . Reasons for non-attendance at cervical screening as reported by non-attendees in Sweden. J Psychosom Obstet Gynaecol. 2008; 29(1):23-31. DOI: 10.1080/01674820701504619. View

12.

Fitch K, Bohn J, Emerson J, Boniface E, Bruegl A . Acceptability of human papillomavirus self-collection and the role of telehealth: a prospective, randomized study stratified by menopausal status. Int J Gynecol Cancer. 2023; 34(1):19-27. DOI: 10.1136/ijgc-2023-004935. View

13.

Interis E, Anakwenze C, Aung M, Jolly P . Increasing Cervical Cancer Awareness and Screening in Jamaica: Effectiveness of a Theory-Based Educational Intervention. Int J Environ Res Public Health. 2015; 13(1):ijerph13010053. PMC: 4730444. DOI: 10.3390/ijerph13010053. View

14.

Senkomago V, Saraiya M . Examining Acceptability of Self-Collection for Human Papillomavirus Testing Among Women and Healthcare Providers with a Broader Lens. J Womens Health (Larchmt). 2017; 26(6):597-599. PMC: 5569881. DOI: 10.1089/jwh.2017.6384. View

15.

Mengesha M, Chekole T, Hidru H . Uptake and barriers to cervical cancer screening among human immunodeficiency virus-positive women in Sub Saharan Africa: a systematic review and meta-analysis. BMC Womens Health. 2023; 23(1):338. PMC: 10294344. DOI: 10.1186/s12905-023-02479-w. View

16.

Pretsch P, Spees L, Brewer N, Hudgens M, Sanusi B, Rohner E . Effect of HPV self-collection kits on cervical cancer screening uptake among under-screened women from low-income US backgrounds (MBMT-3): a phase 3, open-label, randomised controlled trial. Lancet Public Health. 2023; 8(6):e411-e421. PMC: 10283467. DOI: 10.1016/S2468-2667(23)00076-2. View

17.

Camara H, Zhang Y, Lafferty L, Vallely A, Guy R, Kelly-Hanku A . Self-collection for HPV-based cervical screening: a qualitative evidence meta-synthesis. BMC Public Health. 2021; 21(1):1503. PMC: 8336264. DOI: 10.1186/s12889-021-11554-6. View

18.

Fargnoli V, Petignat P, Burton-Jeangros C . To what extent will women accept HPV self-sampling for cervical cancer screening? A qualitative study conducted in Switzerland. Int J Womens Health. 2015; 7:883-8. PMC: 4639555. DOI: 10.2147/IJWH.S90772. View

19.

Perkins R, Guido R, Castle P, Chelmow D, Einstein M, Garcia F . 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020; 24(2):102-131. PMC: 7147428. DOI: 10.1097/LGT.0000000000000525. View

20.

Suk R, Hong Y, Rajan S, Xie Z, Zhu Y, Spencer J . Assessment of US Preventive Services Task Force Guideline-Concordant Cervical Cancer Screening Rates and Reasons for Underscreening by Age, Race and Ethnicity, Sexual Orientation, Rurality, and Insurance, 2005 to 2019. JAMA Netw Open. 2022; 5(1):e2143582. PMC: 8767443. DOI: 10.1001/jamanetworkopen.2021.43582. View